Introduction of the biosimilar trastuzumab and its impact on patients and services

Practical guidance on the assessment of biosimilar monoclonal antibodies: A physician's perspective

Continuous treatment versus fixed duration therapy: Using real-world evidence to guide treatment paradigms for multiple myeloma

Transitioning from bortezomib to ixazomib in patients with multiple myeloma

HPV: The global threat of vaccination hesitancy

Symptomatic control in palliative medicine

Optimising regorafenib dosing in mCRC

Recent advances in smouldering and relapsed or refractory multiple myeloma

Latest updates in HER2-positive metastatic breast cancer: The NALA and SOPHIA trials

Providing quality patient care and service using the Oncology Care Model

Oncology Care Model: Improving value-based care

Cancer control in Africa - Special Issue